This inventor holds 3 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: The Innovations of Edward Holson
Introduction
Edward Holson is a notable inventor based in New York, NY, who has made significant contributions to the field of chemistry. He holds three patents, showcasing his innovative approach to developing new compounds that have potential applications in modulating chemokine receptor activity.
Latest Patents
Holson's latest patents focus on pyrrolidine and piperidine modulators of chemokine receptor activity. These inventions are directed towards compounds that are useful in modulating various chemokine receptors, including CCR-1, CCR-2, CCR-2A, CCR-2B, CCR-3, CCR-4, CCR-5, CXCR-3, and CXCR-4. The detailed chemical formulas and structures of these compounds highlight their potential in therapeutic applications.
Career Highlights
Edward Holson is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to explore innovative solutions in the pharmaceutical industry, particularly in the development of new therapeutic agents.
Collaborations
Throughout his career, Holson has collaborated with esteemed colleagues such as Jeffrey John Hale and Malcolm MacCoss. These collaborations have contributed to the advancement of research and development in their respective fields.
Conclusion
Edward Holson's contributions to the field of chemistry through his patents and collaborations reflect his dedication to
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile